Tirzepatide cost ranges from $25/month with optimal insurance and savings cards to $1,200/month paying cash. Understanding your options helps you access this effective medication affordably.
This guide covers: Retail pricing for Mounjaro and Zepbound, Insurance coverage differences, Manufacturer savings programs, Compounded tirzepatide costs, Cost comparison with semaglutide.
Note: Both contain identical medication (tirzepatide).
For Diabetes (Mounjaro): Generally covered with prior authorization, Coverage rate: 70-80% of plans, Typical copays: $50-$150/month, May require metformin trial first.
For Weight Loss (Zepbound): Poor coverage, many plans exclude, Coverage rate: 20-30% of plans, Typical copays: $100-$300/month when covered, Strict medical necessity requirements.
Mounjaro: Reduce copay to $25/month, For commercially insured patients, Not valid for government insurance, Most accessible savings program.
Zepbound: Reduce copay to $25-$500/month, More restrictions than Mounjaro, Plan-dependent savings amount, May have coverage limits.
Eligibility: Commercial insurance required, Must have prescription, Insurance must cover medication, Apply at Mounjaro.com or Zepbound.com.
1. Leverage Diabetes Diagnosis (if applicable) – Mounjaro has better coverage than Zepbound – Same medication, better access – Weight loss is beneficial side effect.
2. Apply for Savings Programs – Eli Lilly Savings Card – Patient assistance programs – Check eligibility before filling prescription.
3. Consider Compounded Options – Verify 503B pharmacy registration – Ask about third-party testing – Compare total cost including supplies.
4. Shop Around – Prices vary by pharmacy – Check both retail and mail-order – Factor in shipping costs.
Without insurance, Mounjaro costs $900-$1,050/month and Zepbound costs $1,000-$1,200/month. With insurance and manufacturer savings cards, costs can be as low as $25/month for Mounjaro. Compounded tirzepatide costs $200-$400/month.
Insurance typically covers Mounjaro for diabetes (70-80% of plans) but rarely covers Zepbound for weight loss (20-30% of plans). Medicare covers Mounjaro for diabetes but cannot cover Zepbound.
For weight loss, Zepbound ($1,000-$1,200/month) is cheaper than Wegovy ($1,300-$1,400/month). For diabetes, Mounjaro and Ozempic cost similarly ($900-$1,000/month). With savings cards, both can be $25/month. Tirzepatide is more effective, producing 15-22.5% weight loss vs 10-15% for semaglutide.
Compounded tirzepatide can be safe from reputable pharmacies but isn’t FDA-approved. Quality varies significantly. Choose 503B outsourcing facilities with third-party testing. The FDA has warned about quality and safety concerns with compounded versions.
Tirzepatide costs $900-$1,200/month without insurance, but manufacturer savings cards and insurance can reduce this to $25-$150/month. Mounjaro typically has better coverage than Zepbound despite being the same medication. Compounded options ($200-$400/month) offer middle-ground pricing.
Next steps: Check insurance coverage for both Mounjaro and Zepbound, apply for Eli Lilly savings card, and compare total annual costs.
This article is for informational purposes only. Prices may vary by location and change over time.
